Hello everyone,

New technology inhibits potent arNOX enzyme in skin cells, removing a destructive source of internal aging.

New research has recently revealed a major, previously hidden source of aging within each of us – an internal aging accelerator in the epidermis, which increases as we age. Present on the surface of our cells, this invisible enemy called age-related NADH oxidase (arNOX) is capable of generating skin damaging free radicals around the clock that can also destroy collagen and elastin and diminish production of these critical proteins.

Individuals that have high arNOX activity in their skin typically look 7 years OLDER than their chronological age, while individuals who have low arNOX activity typically look 7 years YOUNGER.

Our galvanic skin treatment gels now contain a patented technology that targets this previously unknown INTERNAL source of aging – completely inhibiting arNOX activity in the skin.

This technology has been shown in clinical trials performed in conjunction with Purdue and Stanford to eliminate harmful arNOX free radical damage in the skin.

Download the Purdue Study HERE.

Download the Stanford Study HERE.

Download the Pilot Study of the relationship between arNOX levels and skin aging HERE.

The Pharmaceutical giant – GlaxoSmithKline – recently invested $700 Million to acquire a 10% interest in the future development of this scientific breakthrough in skin aging!

Currently, this technology is ONLY available in our galvanic skin treatment gels.

However, beginning October, 2009 this revolutionary arNOX inhibitor will be available in our daily internal supplement line – providing arNOX inhibition throughout the body!

Learn more about our galvanic skin treatment and non-surgical face lift HERE.